Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,394.00
(
-0.62%
)
Dow Jones
46,669.88
(
0.00%
)
Brent Oil
107.96
(
0.83%
)
Bitcoin
68,319.71
(
-0.78%
)
News Focus
News Focus
Post# of 257366
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122852
Boards Moderated 8
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 90047

Monday, 07/12/2010 9:36:08 AM

Monday, July 12, 2010 9:36:08 AM

Post# of 257366
AUXL’s 2Q10 sales of Xiaflex were $2.0M:

http://www.reuters.com/article/idUKSGE66B0FG20100712

Yes, this was the first full quarter of sales. Nevertheless, $2M is chump change; AUXL may have overstated the size of the addressable market for this drug.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today